Tower Research Capital LLC (TRC) - ACUMEN PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,831
-48.6%
2,128
-40.5%
0.00%
-100.0%
Q2 2023$17,196
+143200.0%
3,575
+18.3%
0.00%
Q1 2023$12
-33.3%
3,022
-7.6%
0.00%
-100.0%
Q4 2022$18
-100.0%
3,272
-59.7%
0.00%0.0%
Q3 2022$81,000
+350.0%
8,117
+108.9%
0.00%
Q2 2022$18,000
+80.0%
3,885
+52.1%
0.00%
Q1 2022$10,000
-77.3%
2,555
-60.8%
0.00%
-100.0%
Q4 2021$44,000
+340.0%
6,523
+838.6%
0.00%
Q3 2021$10,0006950.00%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$18,4525.05%
Knollwood Investment Advisory, LLC 1,678,510$9,063,9543.55%
GUARDIAN POINT CAPITAL, LP 300,000$1,620,0001.28%
GREAT POINT PARTNERS LLC 1,116,581$6,029,5371.18%
RA Capital Management 9,770,773$52,762,1741.07%
Deep Track Capital, LP 3,952,000$21,340,8000.90%
Cheyne Capital Management (UK) LLP 55,829$301,4770.53%
SILVERARC CAPITAL MANAGEMENT, LLC 295,115$1,593,6210.46%
COMMODORE CAPITAL LP 498,315$2,6910.41%
Ikarian Capital, LLC 254,945$1,376,7030.33%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders